Leading Dutch researchers in cancer, seven of which from the Hubrecht Institute, are cooperating in Oncode Institute. For the next five years, this independent research institute is funded with 120 million euros by the Dutch Cancer Society (KWF), the ministries of Economic Affairs and Climate Policy (EZK), Education, Culture and Science (OCW) and Health, Welfare and Sports (VWS), Health~Holland, NWO and ZonMw. On February 5th, her Majesty the Queen of the Netherlands will open Oncode Institute together with patients, researchers and partners.
Oncode Institute is an initiative of five leading cancer researchers: René Bernards, Anton Berns (Netherlands Cancer Institute – Antoni van Leeuwenhoek), Hans Bos (UMC Utrecht), Hans Clevers (Hubrecht Institute and Princess Máxima Center) and Jan Hoeijmakers (Erasmus MC and Princess Máxima Center). The institute has three cornerstones: excellent research, intensive cooperation and bringing new treatments faster into the clinic. To this end, Oncode Institute has appointed a team of valorization experts to eventually increase the quality of life of patients.
Cooperation is one of the principles of Oncode – the virtual institute unites 560 academic researchers of 43 research groups, of which seven are groups of the Hubrecht Institute. ‘Oncode Institute has a lot of attention for fundamental cancer research. With a strong valorization team, new discoveries may lead to new cancer treatments’, says Puck Knipscheer, one of the involved principal investigators at the Hubrecht Institute.
On February 5th, 2018, Her Majesty the Queen of the Netherlands will officially open Oncode Institute at the Royal Tropical Institute in Amsterdam. This will happen in the presence of ministers Bruno Bruins (HWS), Ingrid van Engelshoven (ECS), director-general Bertholt Leeftink (EC), among others. Hans Clevers (Hubrecht Institute and Princess Máxima Center), Koos Boering (Dutch Cancer Society), Jan Schellens (Netherlands Cancer Institute – Antoni van Leeuwenhoek), Robbert Dijkgraaf (Institute for Advanced Study, Princeton) and David Livingston (Harvard Cancer Center) will provide keynote lectures.
About Oncode Institute
Oncode Institute is an independent institute that aims to translate fundamental insights of cancer to better and more affordable care as efficient as possible. Leading Dutch cancer researchers are brought together with a common strategy in a mission-driven institute with three cornerstones: excellent research, intensive cooperation and powerful valorization. Until 2022, the Dutch Cancer Society, the ministries of Economic Affairs and Climate Policy (EZK), Education, Culture and Science (OCW) and Health, Welfare and Sports (VWS), Health~Holland, NWO and ZonMw invest 120 million euros in Oncode Institute.
Photo: Puck Knipscheer in her lab at the Hubrecht Institute. (c) Marijn Smulders for Oncode Institute